北京依生兴业科技有限公司 Yisheng Pharma
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Yisheng Biopharma Announces New Breakthrough Results on YS-ON-001 in Multiple Solid Tumor Experiments 2017-08-30 20:00
Yisheng Biopharma Starts Enrollment in Phase 1 Immuno-Oncology Clinical Trial of YS-ON-001 in Patients with Advanced Solid Tumors 2017-05-01 20:00
Yisheng Biopharma to Present at BioPharma Asia Convention 2017 in Singapore 2017-03-15 20:30
US FDA Grants Orphan Drug Designation to Yisheng Biopharma's PIKA Rabies Vaccine 2017-01-04 21:30
The US FDA Granted Orphan Drug Designation to Yisheng Biopharma's Biological Product for Hepatocellular Carcinoma 2016-10-24 20:00
The US FDA Granted Orphan Drug Designation to Yisheng Biopharma's Biological Product for Hepatocellular Carcinoma 2016-10-24 08:00
Yisheng Biopharma and the United States Army Medical Research Institute of Infectious Diseases Announce Positive Animal Results of Vaccine Against Ebola Virus 2016-07-15 21:52
Yisheng Biopharma Announces Positive Results of Phase I Clinical Trial of a Novel Rabies Vaccine with PIKA Adjuvant 2016-01-04 09:00
1 2 3 4